QIAGEN launches enhanced GeneGlobe Design & Analysis Hub, combining curated knowledge, content-based assays and analyses for life science research

Hilden, Germany, and Germantown, Maryland, September 30, 2019 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of its newly enhanced GeneGlobe Design & Analysis Hub, bringing next-level experiment planning, execution and follow-up to life science researchers. GeneGlobe integrates QIAGEN’s deep, manually curated knowledge base on over 10,000 biological entities with the... Read more

Illumina and Broad Institute Announce Agreement to Co-Develop Genomic Secondary Analysis Tools

SAN DIEGO–(BUSINESS WIRE)–Illumina, Inc. (NASDAQ: ILMN) and the Broad Institute of MIT and Harvard today announced they have entered into a collaboration for the co-development of secondary genomic analysis algorithms and software. Top data scientists from both institutions will collaborate to bring together the industry-leading open-source GATK algorithms with the speed and enhanced accuracy of... Read more

Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa

Basel, 30 September 2019 Roche to present results of first prospective trial using blood-based next generation sequencing which successfully identifies people for treatment with Alecensa Efficacy of Alecensa® (alectinib) in people identified to have ALK-positive non-small cell lung cancer using liquid biopsy is consistent with efficacy in those identified by tissue analysis in the pivotal... Read more

Bio-Rad Files New Lawsuit Against 10X Genomics for Patent Infringement

Date: 09/11/2019 HERCULES, Calif.–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that it has filed a patent infringement suit against 10X Genomics, Inc. in the United States District Court for the District of Delaware. In the lawsuit Bio-Rad asserts that 10X Genomics infringes... Read more

Samplix Launches Xdrop™ – Providing PCR-free Target Enrichment of Single Molecules

Herlev, Denmark – September 2nd 2019 – Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity. Xdrop™ enables single molecule resolution and bias free enrichment of genomic regions longer than 100 kb from as little as 1 ng genomic DNA. Xdrop™ fits seamlessly with any... Read more

Fluidigm Revolutionizes Next-Generation Sequencing RNA Library Preparation with Microfluidic Automation

Fluidigm Launches Breakthrough RNA Sequencing Library Preparation Workflow, Delivering Substantial Cost Savings and Efficiency SOUTH SAN FRANCISCO, Calif., Sept. 09, 2019 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the launch of a breakthrough RNA sequencing library preparation workflow that provides substantial cost savings... Read more

European Research Initiative Adopts PacBio Sequel II System to Solve Rare Diseases

MENLO PARK, Calif., Sept. 05, 2019 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB), a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, today announced that its Single Molecule, Real-Time (SMRT®) Sequencing technology has been selected by the European research program SOLVE-RD to help reveal the genetic mechanisms responsible for rare genetic... Read more

Samplix Launches Xdrop™ – Providing PCR-free Target Enrichment of Single Molecules

Pictured: The Xdrop™ system from Samplix. To download this image, please click here. Herlev, Denmark – September 2nd 2019 – Today, Samplix announced the commercial launch of its Xdrop™ sample preparation products for PCR-free target enrichment yet maintaining PCR-level specificity.  Xdrop™ enables single molecule resolution and bias free enrichment of genomic regions longer than 100 kb from... Read more

Merck KGaA, Darmstadt, Germany Granted 20 CRISPR Patents Total Worldwide

Merck KGaA, Darmstadt, Germany today announced that the European, Israeli, South Korean and U.K. intellectual property offices have issued formal notices allowing its Life Science business’ patent… 19 AUG 2019 | DARMSTADT, GERMANY Patent offices in Europe, Israel, South Korea and U.K. issue seven additional grants for company’s CRISPR genome-editing technology Company has 20 allowed CRISPR patents... Read more